Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Innate Pharma (IPHA) Equity Average (2018)

Historic Equity Average for Innate Pharma (IPHA) over the last 1 years, with Q4 2018 value amounting to $146.0 million.

  • Innate Pharma's Equity Average changed N/A to $146.0 million in Q4 2018 from the same period last year, while for Dec 2018 it was $146.0 million, marking a year-over-year change of. This contributed to the annual value of $215.8 million for FY2019, which is 4774.06% up from last year.
  • Latest data reveals that Innate Pharma reported Equity Average of $146.0 million as of Q4 2018.
  • In the past 5 years, Innate Pharma's Equity Average registered a high of $146.0 million during Q4 2018, and its lowest value of $146.0 million during Q4 2018.